Antibiotic susceptibilities, streptococcal pyrogenic exotoxin gene profiles among clinical isolates of group C or G Streptococcus dysgalactiae subsp. equisimilis & of group G S. anginosus group at a tertiary care centre
暂无分享,去创建一个
P. Mathur | Neetu J. Jain | B. Behera | M. Misra | Sarman Singh | N. Bhardwaj | A. Kapil
[1] T. Menon,et al. Genotypic characterization of toxigenic group C and G streptococci isolated in Chennai, South India , 2011, Folia Microbiologica.
[2] Haruo Watanabe,et al. Invasive infection caused by Streptococcus dysgalactiae subsp. equisimilis: characteristics of strains and clinical features , 2011, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[3] S. Skrede,et al. emm gene diversity, superantigen gene profiles and presence of SlaA among clinical isolates of group A, C and G streptococci from western Norway , 2010, European Journal of Clinical Microbiology & Infectious Diseases.
[4] G. S. Chhatwal,et al. Contribution of Streptococcus anginosus to Infections Caused by Groups C and G Streptococci, Southern India , 2010, Emerging infectious diseases.
[5] P. V. Bramhachari,et al. Disease burden due to Streptococcus dysgalactiae subsp. equisimilis (group G and C streptococcus) is higher than that due to Streptococcus pyogenes among Mumbai school children. , 2010, Journal of medical microbiology.
[6] B. Spellerberg,et al. E M E R G I N G I N F E C T I O N S I N V I T E D a R T I C L E Human Infections Due to Streptococcus Dysgalactiae Subspecies Equisimilis , 2022 .
[7] M. Arvand,et al. Prevalence of erythromycin and clindamycin resistance among clinical isolates of the Streptococcus anginosus group in Germany. , 2009, Journal of medical microbiology.
[8] D. Livermore,et al. Non-susceptibility trends among enterococci and non-pneumococcal streptococci from bacteraemias in the UK and Ireland, 2001-06. , 2008, The Journal of antimicrobial chemotherapy.
[9] J. Carapetis,et al. Superantigen genes in group A streptococcal isolates and their relationship with emm types. , 2008, Journal of medical microbiology.
[10] M. McDonald,et al. Epidemiology of Streptococcus dysgalactiae subsp. equisimilis in Tropical Communities, Northern Australia , 2007, Emerging infectious diseases.
[11] A. Sandgren,et al. Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] Yu-ling Zheng,et al. Epidemiological analysis of group A streptococci recovered from patients in China. , 2006, Journal of medical microbiology.
[13] P. Coll,et al. Superantigen gene profile, emm type and antibiotic resistance genes among group A streptococcal isolates from Barcelona, Spain. , 2006, Journal of medical microbiology.
[14] Ronald N. Jones,et al. Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004). , 2006, Diagnostic microbiology and infectious disease.
[15] M. Davies,et al. Distribution of group A streptococcal virulence genes in group C and G streptococci , 2006 .
[16] Ronald N. Jones,et al. Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004). , 2006, Diagnostic microbiology and infectious disease.
[17] B. Herrmann,et al. Identification of 43 Streptococcus Species by Pyrosequencing Analysis of the rnpB Gene , 2005, Journal of Clinical Microbiology.
[18] P. Mathur,et al. Prevalence of group G & group C streptococci at an Indian tertiary care centre. , 2004, The Indian journal of medical research.
[19] T. Hasegawa,et al. Characterization of Group C and G Streptococcal Strains That Cause Streptococcal Toxic Shock Syndrome , 2004, Journal of Clinical Microbiology.
[20] E. Charpentier,et al. Toxin-gene profile heterogeneity among endemic invasive European group A streptococcal isolates. , 2003, The Journal of infectious diseases.
[21] J. Schellekens,et al. Site-Specific Manifestations of Invasive Group A Streptococcal Disease: Type Distribution and Corresponding Patterns of Virulence Determinants , 2003, Journal of Clinical Microbiology.
[22] Gail Williams. Group C and G Streptococci Infections: Emerging Challenges , 2003, American Society for Clinical Laboratory Science.
[23] D. Bessen,et al. Presence of streptococcal pyrogenic exotoxin A and C genes in human isolates of group G streptococci. , 2003, FEMS microbiology letters.
[24] E. Straube,et al. Superantigen-like gene(s) in human pathogenic Streptococcus dysgalactiae, subsp equisimilis: genomic localisation of the gene encoding streptococcal pyrogenic exotoxin G (speG(dys)). , 2002, FEMS immunology and medical microbiology.
[25] K. Yuen,et al. Group G Beta-Hemolytic Streptococcal Bacteremia Characterized by 16S Ribosomal RNA Gene Sequencing , 2001, Journal of Clinical Microbiology.
[26] M. Ferraro. Performance standards for antimicrobial susceptibility testing , 2001 .
[27] P. Vandamme,et al. Taxonomic study of lancefield streptococcal groups C, G, and L (Streptococcus dysgalactiae) and proposal of S. dysgalactiae subsp. equisimilis subsp. nov. , 1996, International journal of systematic bacteriology.
[28] M. Kotb,et al. Bacterial pyrogenic exotoxins as superantigens , 1995, Clinical microbiology reviews.
[29] D. Beighton,et al. Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (the Streptococcus milleri group): association with different body sites and clinical infections , 1992, Journal of clinical microbiology.
[30] K. Ruoff. Streptococcus anginosus ("Streptococcus milleri"): the unrecognized pathogen , 1988, Clinical Microbiology Reviews.